Companies: 10,795·Total market cap: $144.5T
Soleno Therapeutics, Inc.

Soleno Therapeutics, Inc.

SLNONASDAQHealthcare
$53.01
+$0.00(+0.00%)
Market Cap$2.8B
P/E Ratio
52W High$90.3199
52W Low$29.43
Overview

Soleno Therapeutics, Inc. (SLNO) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · SLNO · as of Jun 8, 2026

Key Statistics

EPS (TTM)$1.96slno eps ttm · slno earnings per shareEarnings history
PE Ratio (TTM)27.1×slno pe ratio ttm · slno price to earningsPE Ratio deep dive
Revenue (TTM)$285.0Mslno revenue ttm · slno annual revenueFull revenue history
Dividend YieldNo Dividenddoes slno pay dividends · slno dividend yieldDividend history
Shares Outstanding53.2Mslno shares outstanding · slno floatShares outstanding history
Next EarningsAug 5, 2026Est.slno earnings date · slno next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$190.4M
202320242025
soleno therapeutics, inc. revenue · slno revenue 2025
FY 2025Net Income$20.9M▲ +111.88% YoY
202320242025
soleno therapeutics, inc. net income · slno profit 2025
FY 2025EPS$0.41▲ +109.36% YoY
202320242025
slno eps · soleno therapeutics, inc. earnings per share 2025
TTM:Revenue: $285.0MNet Income: $96.0MEPS: $1.96View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy13 analystsis slno a buy · slno analyst rating
Strong Buy
0
Buy
8
Hold
5
Sell
0
Strong Sell
0
12-Month Price Target
$53.00Low
$53.01Current
$80.00Avg Target50.91% upside
$107.00High
slno price target · slno 12 month forecast

Total: 13 · Buy rate: 61.5%

The SLNO analyst consensus is Buy, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month price target is $80.00, representing +50.91% upside from the current price of $53.01.

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.11%
3M+33.59%
YTD+14.49%
1Y-31.80%
5Y-36.89%

About Soleno Therapeutics, Inc.

CEOAnish Bhatnagar
IPO DateNov 13, 2014
Employees115
CountryUS

Soleno Therapeutics, Inc. a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is …

what is soleno therapeutics, inc. · slno stock overview · soleno therapeutics, inc. company profile · who is soleno therapeutics, inc. ceo · slno NASDAQ · soleno therapeutics, inc. headquarters · soleno therapeutics, inc. business segments

About Stock Overview & Key Data

Soleno Therapeutics, Inc. (SLNO) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 13, 2014. As of the latest trading session, SLNO stock price is $53.01, with a market capitalization of $2.8B. The stock has returned -31.80% over the past 12 months and +14.49% year-to-date.

According to 13 Wall Street analysts, the consensus rating for Soleno Therapeutics, Inc. stock is Buy, with an average 12-month price target of $80.00. In fiscal year 2025, Soleno Therapeutics, Inc. reported revenue of $190.4M and net income of $20.9M. For detailed data — including Soleno Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Soleno Therapeutics, Inc. (SLNO) stock price is $53.01. The stock is traded on NASDAQ under the ticker symbol SLNO. The 52-week range is $29.43 – $90.32.

SLNO stock priceSLNO quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice